News - Ani Bookmark

Metagenomics Sequencing services for tumour-associated Bacteria

Bellasmith121 Dec, 2022News

With these data, our customers will acquire deep knowledge, which is extremely useful in investigating its association with tumor clinical characteristics as well as host expression profiles. Creative Biolabs has developed the world-leading SuPrecision™ Platform, and our proficient scientists provide metagenomics sequencing to are assisst you in cancer-associated bacteria studies.

PXDN Tetramer

Bellasmith121 Dec, 2022News

Our cutting-edge hybridoma development and phage display platforms allow the production of the most comprehensive list of recombinant antibody products and extensive service portfolio at the most competitive price. Our products range from antibody / peptide libraries, Biosimilar cell lines, Chimeric antigen receptor (CAR) products, antibody-drug conjugates (ADCs) to engineered antibodies such as therapeutic antibodies, single-domain antibodies, bispecific antibodies and intrabodies. We also provide professional custom antibody discovery and engineering services, featuring phage display library construction, antibody humanization, chimerization, engineered antibody production (Fab, scFc, tribody, bispecific antibody, SdAb, minibody, etc.), antibody labeling, hybridoma/stable cell line development, membrane protein production and cGMP-manufacturing which enable larger scale antibody production for development of animal-based assays and clinical trials.

Cas9 Tetramer

Bellasmith121 Dec, 2022News

Our cutting-edge hybridoma development and phage display platforms allow the production of the most comprehensive list of recombinant antibody products and extensive service portfolio at the most competitive price. Our products range from antibody / peptide libraries, Biosimilar cell lines, Chimeric antigen receptor (CAR) products, antibody-drug conjugates (ADCs) to engineered antibodies such as therapeutic antibodies, single-domain antibodies, bispecific antibodies and intrabodies. We also provide professional custom antibody discovery and engineering services, featuring phage display library construction, antibody humanization, chimerization, engineered antibody production (Fab, scFc, tribody, bispecific antibody, SdAb, minibody, etc.), antibody labeling, hybridoma/stable cell line development, membrane protein production and cGMP-manufacturing which enable larger scale antibody production for development of animal-based assays and clinical trials.

mRNA structure modification

Bellasmith121 Dec, 2022News

During developments of mRNA therapeutics, the stability and translation efficiency remains two pivotal issues at early stage and may have influences throughout the overall development processes even the large scale manufacture and they need to be addressed as early as possible. To this end, Creative Biolabs has developed a comprehensive platform enabling optimization of mRNA synthesis, modification, and delivery method.

what is RNA fluorescence assay

Bellasmith121 Dec, 2022News

During developments of mRNA therapeutics, the stability and translation efficiency remains two pivotal issues at early stage and may have influences throughout the overall development processes even the large scale manufacture and they need to be addressed as early as possible. To this end, Creative Biolabs has developed a comprehensive platform enabling optimization of mRNA synthesis, modification, and delivery method.

lyophilized yfgh antibody

Bellasmith121 Dec, 2022News

Creative Biolabs was established as a biotechnology company specializing in developing and production of antibodies and also a service provider for customized products and relevant services. The company was founded by a group of scientists and entrepreneurs who are committed to changing the traditional antibody model and establishing a new service platform. Employees at Creative Biolabs are composed of elites (Masters & PhD) from top universities worldwide. As an antibody customization service provider, we are dedicated to the research and development of antibodies to animals, plants and microorganisms, focusing on the research needs of different models of biological antibodies and becoming a direct supplier of products.

microfluidics based point-of-care diagnostics

Bellasmith121 Dec, 2022News

Point-of-care technology (POCT) diagnostic systems are tools that can rapidly lead to in vitro diagnostic (IVD) results by non-trained personnel at a patient site in varieties of locations such as the field, the home, the ambulance, or the hospital. To this day, diagnostic tests are typically operated at laboratories equipped with bench-top analyzers and managed by trained personnel. That is to say, there have been a few days to wait before patients receive their testing results.

microfluidic protein detection

Bellasmith121 Dec, 2022News

As a leading service provider in the field of microfluidic systems, Creative Biolabs has launched an integrated platform for the development of a wide range of rapid and sensitive microfluidic chips to achieve protein digestion, identification, and analysis using electrospray ionization mass spectrometry (ESI-MS) or many other mass spectrometry (MS) detections.

Next Generation Probiotics Services for Autism Spectrum Disorder (ASD)

Bellasmith121 Dec, 2022News

With the growing research on probiotics and the integral part, they play in the health of the gastric intestinal (GI) tract and the whole body, their inclusions as an integrative treatment may be of great use for children with ASD. Creative Biolabs provides a series of next-generation probiotics (NGPs) discovery and analysis services characterized by quality, predictability, delivery, and customization. Our employees have the operational courage and scientific background that you need for your success.

Football Transfer News, Live Updates: Chelsea approach Man United's Garnacho

Sportsliveresults21 Dec, 2022News

Premier League giants have showed their interest in Manchester United wonderkid Garnacho and Juventus midfielder Weston McKennie. Reportedly, Barcelona forward Memphis Depay, defenders Hector Bellerin, Franck Kessie, Jordi Alba and captain Sergio Busquets are likely to move to a new club in January. While Depay,

News Bookmarks

Recent Profiles